Evidence map›Paper›PMID 40263354›Full record

ArticleScientific reports2025

Comprehensive analysis of 42 psilocybin-producing fungal strains reveals metabolite diversity and species-specific clusters.

Jonathan Cohen, Liron Sulimani, Shiri Procaccia, Yaniv Lerenthal, Looz Milay, Ido Taran, Anna Shapira, David Meiri

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Interpol review of forensic drug chemistry, 2022-2025.Forensic science international. Synergy · 2026
    Review
  2. Surprising Variability in Tryptamine Profiles ofJournal of fungi (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jonathan CohenLaboratory of Cancer Biology and Natural Drug Discovery, Faculty of Biology, Technion-Israel Institute of Technology, 3200003, Haifa, Israel.
Liron SulimaniThe Kleifeld Laboratory, Faculty of Biology, Technion-Israel Institute of Technology, 3200003, Haifa, Israel.
Shiri ProcacciaLaboratory of Cancer Biology and Natural Drug Discovery, Faculty of Biology, Technion-Israel Institute of Technology, 3200003, Haifa, Israel.
Yaniv LerenthalPsygaBio, Caesarea, Israel.
Looz MilayPsygaBio, Caesarea, Israel.
Ido TaranPsygaBio, Caesarea, Israel.
Anna ShapiraLaboratory of Cancer Biology and Natural Drug Discovery, Faculty of Biology, Technion-Israel Institute of Technology, 3200003, Haifa, Israel.
David MeiriLaboratory of Cancer Biology and Natural Drug Discovery, Faculty of Biology, Technion-Israel Institute of Technology, 3200003, Haifa, Israel. dmeiri@technion.ac.il.

Funding

PsygaBio 2031221
6 · The paper itself

Abstract

Psilocybin-producing fungi have garnered attention due to accumulating evidence regarding the therapeutic potential of their principal component psilocybin. This diverse group of fungi harbors a wealth of less-studied metabolites, however, thus far most research has addressed them as a cohesive group. By optimizing an approach for extraction and analysis, we examined the metabolomes of 42 distinct fungi strains and show that the breadth and diversity of metabolites within and between 9 species. We integrated and validated the reproducible and reliable extraction of fruiting bodies followed by chromatographic separation, quantification and identification of their known and yet to be identified secondary metabolites. The optimal extraction of fruiting bodies for high yield of indole alkaloids was achieved using a 1:20 tissue:solvent ratio, 25:75 H

Indexed as

FungiMetabolomePsilocybinChromatography, High Pressure LiquidHallucinogensMetabolomicsSpecies SpecificityTandem Mass SpectrometryHallucinogensPsilocybinDephosphorylationFungal extractionFungal metabolomeLiquid chromatographyPsilocybinPsilocybin-producing fungi

Identifiers

PMID40263354
PMCPMC12015540

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.